Related Experiment Video
Updated: Dec 21, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53: 800 million years of evolution and 40 years of discovery
1Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA. alevine@ias.edu.
Abstract:
The evolutionarily conserved p53 protein and its cellular pathways mediate tumour suppression through an informed, regulated and integrated set of responses to environmental perturbations resulting in either cellular death or the maintenance of cellular homeostasis. The p53 and MDM2 proteins form a central hub in this pathway that receives stressful inputs via MDM2 and respond via p53 by informing and altering a great many other pathways and functions in the cell. The MDM2-p53 hub is one of the hubs most highly connected to other signalling pathways in the cell, and this may be why TP53 is the most commonly mutated gene in human cancers. Initial or truncal TP53 gene mutations (the first mutations in a stem cell) are selected for early in cancer development inectodermal and mesodermal-derived tissue-specific stem and progenitor cells and then, following additional mutations, produce tumours from those tissue types. In endodermal-derived tissue-specific stem or progenitor cells, TP53 mutations are functionally selected as late mutations transitioning the mutated cell into a malignant tumour. The order in which oncogenes or tumour suppressor genes are functionally selected for in a stem cell impacts the timing and development of a tumour.
Insights
The p53 protein and its pathway regulate cell responses to stress, preventing tumors. TP53 mutations are common in cancer and their timing in stem cells affects tumor development.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The p53 protein is a critical tumor suppressor involved in cellular responses to environmental stress.
- The MDM2-p53 complex acts as a central signaling hub, integrating stress signals and modulating cellular functions.
- TP53 is the most frequently mutated gene in human cancers, highlighting its importance in oncogenesis.
Purpose of the Study:
- To elucidate the role of the p53 pathway and TP53 mutations in tumor suppression and cancer development.
- To investigate how the timing of TP53 mutations in different stem cell lineages influences tumor progression.
Main Methods:
- Analysis of the p53 and MDM2 protein interaction and signaling pathways.
- Examination of TP53 mutation patterns in various tissue-derived stem and progenitor cells.
- Correlation of mutation timing with tumor development and progression.
Main Results:
- The p53 pathway mediates tumor suppression through regulated cellular responses, including cell death or homeostasis.
- The MDM2-p53 hub is highly interconnected with other cellular pathways, explaining TP53's frequent mutation in cancer.
- TP53 mutations are selected early in ectodermal and mesodermal-derived cancers, but late in endodermal-derived cancers.
Conclusions:
- The p53 pathway is a key regulator of tumor suppression, responding to cellular stress.
- The timing of TP53 mutations in stem cells is crucial for determining cancer type and developmental trajectory.
- Understanding the role of p53 and mutation timing can inform cancer prevention and treatment strategies.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...

